Macrophage colony-stimulating factor (M-CSF) augments cytokine induction by lipopolysaccharide (LPS)-stimulation and by bacterial infections in mice

被引:14
作者
Hanamura, T [1 ]
Asakura, E [1 ]
Tanabe, T [1 ]
机构
[1] GREEN CROSS CO,CENT RES LAB,HIRAKATA,OSAKA 573,JAPAN
来源
IMMUNOPHARMACOLOGY | 1997年 / 37卷 / 01期
关键词
macrophage colony-stimulating factor; priming; lipopolysaccharide; monokine;
D O I
10.1016/S0162-3109(96)00166-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We studied the effects of M-CSF on cytokine induction in vivo by LPS or by bacterial infection by comparing between the serum cytokine levels of mice administered with and without M-CSF. M-CSF at 250 mu g/kg/day for 3 days significantly augmented serum IL-6 level induced by a subsequent injection of 25 mu g/kg of LPS. The augmented IL-B-induction was dose-dependent from 50 to 1250 mu g/kg/day of M-CSF, and required 2- to 3-doses of M-CSF at 250 mu g/kg/day. Mice primed with M-CSF induced IL-6 in response to a 5-fold lower dose of LPS, and also produced higher levels of IL-1 alpha, IL-10, GM-CSF, TNF-alpha, and IFN-gamma than control mice. The priming effect of M-CSF was transient and reversible, and elicited independently of T-cells. An injection with intact bacteria, such as Gram-negative Escherichia coli and Gram-positive Staphylococcus aureus also induced IL-6 in normal mice, and M-CSF administration augmented the induction of these cytokines. These results showed that M-CSF positively regulates LPS-dependent and -independent cytokine induction, suggesting a defensive effect against infectious agents through enhanced cytokine production. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:15 / 23
页数:9
相关论文
共 41 条
[31]   INDUCTION OF TUMOR-NECROSIS-FACTOR IN MICE BY RECOMBINANT HUMAN MACROPHAGE-COLONY-STIMULATING FACTOR [J].
SAKURAI, T ;
SUZU, S ;
YAMADA, M ;
YANAI, N ;
KAWASHIMA, T ;
HATAKE, K ;
TAKAKU, F ;
MOTOYOSHI, K .
JAPANESE JOURNAL OF CANCER RESEARCH, 1994, 85 (01) :80-85
[32]  
SAMPSONJOHANNES A, 1988, J IMMUNOL, V141, P3680
[33]   HUMAN MACROPHAGE COLONY-STIMULATING FACTOR HETEROGENEITY RESULTS FROM ALTERNATIVE MESSENGER-RNA SPLICING, DIFFERENTIAL GLYCOSYLATION, AND PROTEOLYTIC PROCESSING [J].
SHADLE, PJ ;
ALDWIN, L ;
NITECKI, DE ;
KOTHS, K .
JOURNAL OF CELLULAR BIOCHEMISTRY, 1989, 40 (01) :91-107
[34]   THE C-FMS PROTO-ONCOGENE PRODUCT IS RELATED TO THE RECEPTOR FOR THE MONONUCLEAR PHAGOCYTE GROWTH-FACTOR, CSF-1 [J].
SHERR, CJ ;
RETTENMIER, CW ;
SACCA, R ;
ROUSSEL, MF ;
LOOK, AT ;
STANLEY, ER .
CELL, 1985, 41 (03) :665-676
[35]  
THOMASSEN MJ, 1990, J BIOL RESP MODIF, V9, P87
[36]  
VOGEL SN, 1984, INTERFERON IMMUNE SY, P35
[37]  
WARREN MK, 1986, J IMMUNOL, V137, P2281
[38]   REGULATION OF GAMMA-INTERFERON PRODUCTION BY NATURAL-KILLER-CELLS IN SCID MICE - ROLES OF TUMOR-NECROSIS-FACTOR AND BACTERIAL STIMULI [J].
WHERRY, JC ;
SCHREIBER, RD ;
UNANUE, ER .
INFECTION AND IMMUNITY, 1991, 59 (05) :1709-1715
[39]   HUMAN CSF-1 - MOLECULAR-CLONING AND EXPRESSION OF 4-KB CDNA-ENCODING THE HUMAN URINARY PROTEIN [J].
WONG, GG ;
TEMPLE, PA ;
LEARY, AC ;
WITEKGIANNOTTI, JS ;
YANG, YC ;
CIARLETTA, AB ;
CHUNG, M ;
MURTHA, P ;
KRIZ, R ;
KAUFMAN, RJ ;
FERENZ, CR ;
SIBLEY, BS ;
TURNER, KJ ;
HEWICK, RM ;
CLARK, SC ;
YANAI, N ;
YOKOTA, H ;
YAMADA, M ;
SAITO, M ;
MOTOYOSHI, K ;
TAKAKU, F .
SCIENCE, 1987, 235 (4795) :1504-1508
[40]  
ZANETTI G, 1992, J IMMUNOL, V148, P1890